NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/11/2025
Back to search
Official data from USPTO
VAPOURSOFT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
12/12/2025
Trademark type
Word
Nice classes
10
Filing date
12/14/2020
Registration date
01/17/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/17/2023
Last transaction
12/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
LAM,HAI-LY HUYNH
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Consort Medical Limited
Representatives
Charles P. Guarino Moser Taboada
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Hydrofluoroalkanes (HFA) powered and liquefied gas powered apparatus and instruments for use in or in relation to drug and pharmaceutical delivery deviceshydrofluoroalkanes (HFA) powered drug delivery systems in the nature of infusion and injection devices for administering drugs; hydrofluoralkanes (HFA) powered medical syringesmedical fluid auto-injectors for administering pharmaceuticals and drugs and apparatus and devices for the inhalation or injection of pharmaceuticals and drugsinjection needlesmedical fluid auto-injectors and syringes; hydrofluoralkanes (HFA) powered catheterstransfusion sets and injection syringes for administering drugs and pharmaceuticalsalso incorporating audiovisual and/or tactile patient feedback mechanisms relating to drug and pharmaceutical delivery dosagemeasuring and monitoring information; hydrofluoralkanes (HFA) powered medical syringesmedical fluid auto-injectorsdrug delivery systems comprised of implantable drug delivery ports incorporating audiovisual and/or tactile patient feedback mechanisms to convey dosagemeasuringmonitoring data for the purpose of facilitating and monitoring drug and pharmaceutical delivery and administration; medical syringes; medical syringe stoppers; hydrofluoroolefin (HFO) powered medical fluid auto-injectors and medical fluid injectors; hydrofluoroolefin (HFO) powered apparatus and devices for administering pharmaceuticals and drugsmedical apparatus in the nature of infusion and injection devices for administering drugsmedical tubing for administering drugshypodermic needles; hydrofluoroolefin (HFO) powered drug delivery apparatusdrug delivery systems comprised of drug delivery catheters and electromagnetic drug delivery apparatus for medical use; medical fluid auto-injectors; medical fluid injectors; disposable syringes and medical fluid injectors; hypodermic syringes; apparatus and devices for administering pharmaceuticals and drugsmedical apparatus in the nature of infusion and injection devices for administering drugsmedical tubing for administering drugshypodermic needles; sterile medical syringes and medical fluid auto-injectors for the administration of pharmaceuticals and drugs; cartridges sold empty and specially adapted for medical syringes; nozzles sold empty and specially adapted for medical syringes; drug delivery apparatusdrug delivery systems comprised of drug delivery catheters and electromagnetic drug delivery apparatus for medical use; oral and nasal medication dispensersaerosol dispensers for medical use; aerosol dispensers for medical purposes; structural replacement parts and fittings for all the aforesaid goods
Publications
History of USPTO decisions and trademark events.
40 publications found
RNWL
INTERNATIONAL REGISTRATION RENEWED
02/29/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/16/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/26/2023
FIMP
FINAL DISPOSITION PROCESSED
04/26/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/17/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/17/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/17/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/22/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/01/2022
PUBO
PUBLISHED FOR OPPOSITION
11/01/2022
GPNX
NOTIFICATION PROCESSED BY IB
10/31/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/12/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/12/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/23/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/07/2022
RFNT
REFUSAL PROCESSED BY IB
04/10/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/09/2022
GNRT
NON-FINAL ACTION E-MAILED
03/09/2022
CNRT
NON-FINAL ACTION WRITTEN
03/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/08/2022
ATRV
ATTORNEY REVIEW COMPLETED
02/08/2022
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
01/12/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/17/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/16/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/16/2021
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
11/03/2021
RFNT
REFUSAL PROCESSED BY IB
07/18/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/21/2021
RFRR
REFUSAL PROCESSED BY MPU
06/21/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/12/2021
CNRT
NON-FINAL ACTION WRITTEN
06/11/2021
DOCK
ASSIGNED TO EXAMINER
06/07/2021
MAFR
APPLICATION FILING RECEIPT MAILED
01/23/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/19/2021
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
01/14/2021
Continuous trademark protection
Get notified about every new filing that threatens VAPOURSOFT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.